Delivering High-Quality Injectables for Global Healthcare
Arogya Pharma, we specialize in the development and manufacturing of high-quality generic injectables. With advanced sterile facilities and strict regulatory compliance, we ensure cost-effective, safe, and reliable injectable solutions for global pharmaceutical markets.
It is committed to advancing global healthcare by delivering affordable, high-quality generic injectables. Our expertise lies in developing sterile formulations that match the safety, efficacy, and reliability of branded drugs—making critical treatments accessible to patients worldwide. With world-class facilities and a strong regulatory framework, we provide partners with scalable, cost-effective, and globally compliant injectable solutions.
- Proven expertise in sterile injectable formulations
- Scalable production capacity for high-volume supply
- Stringent aseptic and contamination-free processes
- Fully compliant with FDA, WHO, and GMP standards
+ 1(212) 255-511
- Wide therapeutic coverage across multiple segments
- Cost-competitive manufacturing leveraging India’s ecosystem
- Robust quality assurance and regulatory support
- Trusted partner for global pharmaceutical companies
Delivering Quality Through Generic Injectables
Arogya Pharma provides high-quality generic injectable medicines that are safe, effective, and affordable. With advanced sterile facilities and strict global regulatory compliance, we ensure reliable supply to meet critical healthcare needs worldwide. Our expertise spans multiple therapeutic areas, delivering trusted solutions that make essential treatments accessible for patients across the globe.
Make Appointment
Select Doctor
Get Consultation
Frequently asked questions
We understand that healthcare decisions can sometimes feel overwhelming. To make things easier, we’ve gathered answers to some of the most common questions our patients and partners ask. Explore below to find clear, reliable, and helpful information at your fingertips.
Generic injectables are medicines that are equivalent to branded injectable drugs in dosage, safety, strength, quality, and intended use. They offer cost-effective treatment options without compromising patient safety or outcomes.
Generic injectables undergo rigorous testing and must meet strict regulatory standards to ensure they are as safe and effective as their branded counterparts. They are approved by authorities like the FDA, EMA, and WHO.
They are priced lower because manufacturers don’t repeat the extensive clinical trials conducted by the original innovator company. Instead, they prove bioequivalence, reducing development costs and making them more affordable.